Načítá se...
Resection for intrahepatic cholangiocellular cancer: new advances
Intrahepatic cholangiocarcinoma (ICC) is the second most prevalent primary liver neoplasm after hepatocellular carcinoma (HCC), corresponding to 10% to 15% of cases. Pathologies that cause chronic biliary inflammation and bile stasis are known predisposing factors for development of ICC. The inciden...
Uloženo v:
| Vydáno v: | Transl Gastroenterol Hepatol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182028/ https://ncbi.nlm.nih.gov/pubmed/30363713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.08.03 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|